Corient Private Wealth LLC Increases Stock Position in Cognex Corporation $CGNX

Corient Private Wealth LLC raised its position in Cognex Corporation (NASDAQ:CGNX) by 76.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 56,645 shares of the scientific and technical instruments company’s stock after buying an additional 24,490 shares during the period. Corient Private Wealth LLC’s holdings in Cognex were worth $2,045,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the company. Hsbc Holdings PLC boosted its stake in shares of Cognex by 210.3% during the 4th quarter. Hsbc Holdings PLC now owns 58,932 shares of the scientific and technical instruments company’s stock worth $2,127,000 after acquiring an additional 39,937 shares in the last quarter. Pacer Advisors Inc. increased its stake in shares of Cognex by 18.2% in the 4th quarter. Pacer Advisors Inc. now owns 26,562 shares of the scientific and technical instruments company’s stock valued at $956,000 after purchasing an additional 4,084 shares in the last quarter. Kera Capital Partners Inc. increased its stake in shares of Cognex by 118.7% in the 4th quarter. Kera Capital Partners Inc. now owns 12,353 shares of the scientific and technical instruments company’s stock valued at $479,000 after purchasing an additional 6,704 shares in the last quarter. Virtu Financial LLC acquired a new position in Cognex in the 4th quarter worth about $379,000. Finally, Invesco Ltd. boosted its position in Cognex by 9.6% during the fourth quarter. Invesco Ltd. now owns 401,487 shares of the scientific and technical instruments company’s stock worth $14,446,000 after purchasing an additional 35,230 shares in the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.

Insider Activity at Cognex

In related news, VP Darren Marc Long sold 20,252 shares of the company’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the completion of the sale, the vice president owned 3,990 shares of the company’s stock, valued at approximately $264,696.60. This represents a 83.54% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Laura Ann Macdonald sold 41,600 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $65.56, for a total transaction of $2,727,296.00. Following the completion of the sale, the vice president owned 5,258 shares of the company’s stock, valued at approximately $344,714.48. The trade was a 88.78% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 224,847 shares of company stock valued at $14,975,098. Corporate insiders own 1.70% of the company’s stock.

Analysts Set New Price Targets

CGNX has been the topic of several research analyst reports. Seaport Research Partners set a $75.00 price objective on Cognex in a report on Tuesday, May 26th. Sanford C. Bernstein reiterated an “outperform” rating and set a $75.00 target price on shares of Cognex in a research report on Thursday, May 7th. Wall Street Zen raised shares of Cognex from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Needham & Company LLC boosted their price target on shares of Cognex from $67.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, May 8th. Finally, Barclays reissued an “overweight” rating and issued a $75.00 price target (up from $64.00) on shares of Cognex in a report on Monday, May 11th. Two analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $70.43.

Cognex Stock Performance

Shares of CGNX opened at $68.36 on Tuesday. The stock has a 50 day moving average price of $62.59 and a 200 day moving average price of $51.58. Cognex Corporation has a one year low of $31.42 and a one year high of $71.90. The stock has a market capitalization of $11.38 billion, a price-to-earnings ratio of 81.38 and a beta of 1.52.

Cognex (NASDAQ:CGNX) last announced its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.09. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The company had revenue of $268.44 million for the quarter, compared to analysts’ expectations of $245.98 million. During the same quarter in the previous year, the company posted $0.14 EPS. The firm’s quarterly revenue was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, analysts predict that Cognex Corporation will post 1.49 earnings per share for the current year.

Cognex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 4th. Investors of record on Thursday, May 21st were given a dividend of $0.085 per share. The ex-dividend date was Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. Cognex’s payout ratio is presently 40.48%.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.